Chief Financial Officer
Mon, Sep 8, 2025
Sep 8
exercised or converted securities in APLS
15,000 shares @ $10.03
Increased holdings by +11.70%
Net across this filing: -31.50% (-27,729 shares)
Option Exercise
Sale tied to a same-time option exercise
Win rate excludes trades classified as routine (tax, 10b5-1, exercise, gift).
APLSApellis Pharmaceuticals, Inc.
HealthcareBiotechnology